Bundibugyo Ebola Outbreak Expands in DR Congo as Health Authorities Intensify Response

The Democratic Republic of the Congo is confronting a major Ebola outbreak caused by the Bundibugyo virus, with health authorities continuing an intensive response as infections spread across multiple provinces and the geographical reach of the outbreak expands.

The outbreak has now become the largest recorded outbreak of Bundibugyo virus disease and the second-largest Ebola disease outbreak recorded to date. The scale of transmission is placing considerable pressure on healthcare workers, laboratories, contact-tracing teams and emergency response systems.

According to the latest available epidemiological update, the Democratic Republic of the Congo had recorded 7,258 confirmed cases and 3,510 confirmed deaths by September 13. Cases had been identified in 62 health zones across seven provinces.

Outbreak Reaches a Seventh Province

The latest geographical expansion occurred in South-Ubangi province, where a confirmed case was identified in Bulu Health Zone.

South-Ubangi borders both the Central African Republic and the Republic of the Congo. The location of the newly affected area has increased concern about the possibility of further transmission toward international borders.

The expansion demonstrates why surveillance remains a central component of the response. Detecting infections quickly can help health teams isolate patients, identify people who may have been exposed and interrupt chains of transmission before they become more extensive.

Ituri Remains the Main Centre of the Outbreak

Ituri continues to account for the largest share of reported infections.

By September 13, the province had recorded approximately 5,659 confirmed cases and 2,583 deaths. However, health authorities have observed a decline in newly reported infections in Ituri compared with the peak reached during August.

The change is significant because Ituri has been the principal centre of the outbreak for months.

A reduction in transmission could indicate that control measures are having an effect, although the situation remains fluid. A decline in one province does not necessarily mean that the national outbreak is under control.

North Kivu Is Moving in the Opposite Direction

While transmission has been declining in parts of Ituri, North Kivu has been experiencing an increase.

This difference between provinces illustrates the complexity of the outbreak.

Rather than behaving as one uniform epidemic, the outbreak is developing differently in different locations. Some areas are seeing declining transmission, while others continue to report sustained or increasing infections.

For public-health teams, this means that response strategies must be adapted to local circumstances rather than relying on a single nationwide approach.

Why Bundibugyo Virus Presents a Particular Challenge

The current outbreak is caused by Bundibugyo virus, one of the viruses within the Ebola group.

A major challenge is that there is currently no licensed vaccine specifically approved for Bundibugyo virus disease. The only licensed Ebola vaccine, Ervebo, is designed for Ebola virus disease caused by Zaire ebolavirus. WHO states that evidence remains insufficient to determine whether Ervebo provides clinically meaningful protection against Bundibugyo virus in humans.

Consequently, the use of Ervebo against Bundibugyo virus is being studied within research protocols rather than treated as a proven preventive solution.

This distinction is important because different Ebola viruses are biologically distinct, and protection demonstrated against one virus cannot automatically be assumed to work against another.

Vaccination Efforts Continue Among Frontline Workers

Despite the uncertainty surrounding Ervebo’s effectiveness against Bundibugyo virus, vaccination activities have been taking place among healthcare and frontline personnel under research and response protocols.

The purpose is to generate evidence while providing a potential layer of protection to people who face elevated exposure risks.

At the same time, health authorities continue to emphasize measures whose effectiveness does not depend on having a Bundibugyo-specific vaccine.

These include rapid case identification, laboratory testing, isolation and clinical care, contact monitoring, infection-prevention procedures and community engagement.

Contact Tracing Is Critical

Contact tracing is one of the most important tools in controlling Ebola outbreaks.

When a patient is confirmed to have the infection, response teams attempt to identify people who may have had close contact with that individual.

Those contacts can then be monitored for symptoms during the relevant observation period.

The objective is straightforward: identify a potential infection before an infected person unknowingly passes the virus to additional people.

However, contact tracing becomes substantially more difficult when communities are displaced, healthcare access is limited or people must travel frequently between locations.

Conflict and Displacement Complicate the Response

The outbreak is unfolding in an environment where humanitarian challenges are already significant.

Parts of eastern DRC have experienced insecurity, population displacement and limited access to essential services.

These conditions can make it harder for medical teams to reach affected communities.

Displacement can also disrupt normal surveillance systems because people may move between communities before health workers have an opportunity to identify and monitor their contacts.

Healthcare facilities operating under difficult conditions may simultaneously have to manage Ebola patients and provide routine medical services to populations affected by other health problems.

Health Facilities Require Strong Infection Control

Ebola can spread through direct contact with infected body fluids, making infection prevention and control extremely important in medical settings.

Healthcare workers can face substantial risks if protective equipment, isolation procedures and sanitation systems are inadequate.

This is why outbreak response includes not only treatment of infected patients but also protection of the medical workforce.

Hospitals and treatment centres need systems that allow suspected cases to be identified and separated quickly from other patients.

Laboratory capacity is equally important because rapid confirmation can allow public-health teams to begin targeted interventions sooner.

The Outbreak Has Also Had a Regional Dimension

The DRC outbreak has not been completely confined to one country.

Uganda previously reported confirmed Bundibugyo virus cases linked to the outbreak, but the Ugandan outbreak was declared over after the required period without new cases.

The cross-border dimension remains important because people routinely travel between neighbouring countries for trade, family, work and other reasons.

That makes surveillance at formal border crossings and cooperation between neighbouring health authorities important components of outbreak preparedness.

International Risk Is Being Closely Monitored

The scale of the outbreak has prompted continued international monitoring.

At the same time, the risk is not identical everywhere.

Areas immediately affected by the outbreak face very different circumstances from countries geographically distant from the DRC.

This is why public-health risk assessments consider factors such as transmission intensity, population movement, healthcare capacity and the ability to detect imported cases.

The emphasis remains on surveillance and preparedness rather than unnecessary disruption to international travel and trade.

Research Into Treatment Is Underway

Researchers are also working to improve treatment options for Bundibugyo virus disease.

Clinical research is particularly important because evidence from treatments developed for other Ebola viruses cannot automatically establish effectiveness against Bundibugyo virus.

Studies underway during the outbreak could provide valuable information about which therapeutic approaches improve survival and how patients respond at different stages of disease.

Such research may also contribute to preparedness for future outbreaks.

What Happens Next

The latest figures present a mixed picture.

There are indications that transmission has declined from its peak in Ituri, while North Kivu continues to experience increasing transmission. The addition of South-Ubangi as a seventh affected province demonstrates that geographical expansion remains possible.

For this reason, health authorities are continuing to focus on rapid detection, laboratory confirmation, patient care, contact tracing, infection prevention and community engagement.

The central challenge is to prevent newly infected individuals from generating additional chains of transmission while maintaining healthcare access for communities already affected by the outbreak.

A Major Test for Global Health Preparedness

The Bundibugyo Ebola outbreak is demonstrating how quickly an infectious disease emergency can become complicated when transmission occurs across large geographical areas and within communities facing insecurity and displacement.

It is also highlighting the limitations of relying on vaccines developed for a different Ebola virus and the importance of disease-specific research.

While falling transmission in some areas provides an encouraging sign, the continuing spread in other provinces means the response remains an active public-health priority.

The coming weeks will be important for determining whether declining transmission in the most heavily affected areas can be sustained and whether health teams can prevent further geographical expansion.

For the DRC and its international partners, the immediate objective remains clear: detect infections quickly, protect healthcare workers, provide timely treatment, trace contacts and prevent new transmission chains from becoming established.